Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($) |
6 Months Ended | 12 Months Ended | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||
| Cost of Investment | $ 1,138,190,995 | [1],[2],[3],[4],[5] | $ 949,656,720 | [6],[7],[8],[9],[10] | ||||||||||||||||||||
| Common stock, par value per share | $ 0.001 | $ 0.001 | ||||||||||||||||||||||
| Common stock, shares authorized | Unlimited | Unlimited | ||||||||||||||||||||||
| Common stock, shares issued | 22,930,549 | 18,433,976 | ||||||||||||||||||||||
| Common stock, Shares Outstanding | 22,930,549 | 18,433,976 | ||||||||||||||||||||||
| Credit Facility [Member] | ||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||
| Net of deferred financing costs | $ 3,310,440 | $ 0 | ||||||||||||||||||||||
| Borrowings Under Leverage Facility [Member] | ||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||
| Net of deferred financing costs | 6,280,800 | 4,562,245 | ||||||||||||||||||||||
| Non-controlled/non-affiliated [Member] | ||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||
| Cost of Investment | 1,107,066,424 | 918,592,383 | ||||||||||||||||||||||
| Affiliated investments [Member] | ||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||
| Cost of Investment | $ 31,124,571 | $ 31,064,337 | ||||||||||||||||||||||
| ||||||||||||||||||||||||
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Indicates whether number of common shares permitted to be issued is unlimited. Acceptable value is "Unlimited". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of issuance costs recognized in a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, after deduction of accumulated amortization or the effects of subsequent adjustments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cost of the investment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|